Literature DB >> 8112301

A dominant negative mutation in the conserved RNA helicase motif 'SAT' causes splicing factor PRP2 to stall in spliceosomes.

M Plumpton1, M McGarvey, J D Beggs.   

Abstract

To characterize sequences in the RNA helicase-like PRP2 protein of Saccharomyces cerevisiae that are essential for its function in pre-mRNA splicing, a pool of random PRP2 mutants was generated. A dominant negative allele was isolated which, when overexpressed in a wild-type yeast strain, inhibited cell growth by causing a defect in pre-mRNA splicing. This defect was partially alleviated by simultaneous co-overexpression of wild-type PRP2. The dominant negative PRP2 protein inhibited splicing in vitro and caused the accumulation of stalled splicing complexes. Immunoprecipitation with anti-PRP2 antibodies confirmed that dominant negative PRP2 protein competed with its wild-type counterpart for interaction with spliceosomes, with which the mutant protein remained associated. The PRP2-dn1 mutation led to a single amino acid change within the conserved SAT motif that in the prototype helicase eIF-4A is required for RNA unwinding. Purified dominant negative PRP2 protein had approximately 40% of the wild-type level of RNA-stimulated ATPase activity. As ATPase activity was reduced only slightly, but splicing activity was abolished, we propose that the dominant negative phenotype is due primarily to a defect in the putative RNA helicase activity of PRP2 protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8112301      PMCID: PMC394887          DOI: 10.1002/j.1460-2075.1994.tb06331.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

1.  Birth of the D-E-A-D box.

Authors:  P Linder; P F Lasko; M Ashburner; P Leroy; P J Nielsen; K Nishi; J Schnier; P P Slonimski
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

2.  Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP.

Authors:  L A Feig; G M Cooper
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

Review 3.  The Rad3 protein from Saccharomyces cerevisiae: a DNA and DNA:RNA helicase with putative RNA helicase activity.

Authors:  P J Deschavanne; I Harosh
Journal:  Mol Microbiol       Date:  1993-03       Impact factor: 3.501

4.  RNA helicase activity associated with the human p68 protein.

Authors:  H Hirling; M Scheffner; T Restle; H Stahl
Journal:  Nature       Date:  1989-06-15       Impact factor: 49.962

5.  A mechanism to enhance mRNA splicing fidelity: the RNA-dependent ATPase Prp16 governs usage of a discard pathway for aberrant lariat intermediates.

Authors:  S M Burgess; C Guthrie
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

6.  Dominant negative protein kinase mutations that confer a G1 arrest phenotype.

Authors:  M D Mendenhall; H E Richardson; S I Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  Nuclear protein p68 is an RNA-dependent ATPase.

Authors:  R D Iggo; D P Lane
Journal:  EMBO J       Date:  1989-06       Impact factor: 11.598

8.  The splicing factor PRP2, a putative RNA helicase, interacts directly with pre-mRNA.

Authors:  S Teigelkamp; M McGarvey; M Plumpton; J D Beggs
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

9.  DbpA: a DEAD box protein specifically activated by 23s rRNA.

Authors:  F V Fuller-Pace; S M Nicol; A D Reid; D P Lane
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

10.  Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes.

Authors:  A E Gorbalenya; E V Koonin; A P Donchenko; V M Blinov
Journal:  Nucleic Acids Res       Date:  1989-06-26       Impact factor: 16.971

View more
  62 in total

1.  Crystallographic structure of the amino terminal domain of yeast initiation factor 4A, a representative DEAD-box RNA helicase.

Authors:  E R Johnson; D B McKay
Journal:  RNA       Date:  1999-12       Impact factor: 4.942

2.  A mutation in a methionine tRNA gene suppresses the prp2-1 Ts mutation and causes a pre-mRNA splicing defect in Saccharomyces cerevisiae.

Authors:  D H Kim; G Edwalds-Gilbert; C Ren; R J Lin
Journal:  Genetics       Date:  1999-11       Impact factor: 4.562

3.  Crystal structure of a DEAD box protein from the hyperthermophile Methanococcus jannaschii.

Authors:  R M Story; H Li; J N Abelson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

4.  The 100-kda U5 snRNP protein (hPrp28p) contacts the 5' splice site through its ATPase site.

Authors:  N Ismaïli; M Sha; E H Gustafson; M M Konarska
Journal:  RNA       Date:  2001-02       Impact factor: 4.942

5.  Characterization and mutational analysis of yeast Dbp8p, a putative RNA helicase involved in ribosome biogenesis.

Authors:  M C Daugeron; P Linder
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

6.  Characterization of the cold stress-induced cyanobacterial DEAD-box protein CrhC as an RNA helicase.

Authors:  E Yu; G W Owttrim
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

7.  RNA helicase dynamics in pre-mRNA splicing.

Authors:  B Schwer; T Meszaros
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

8.  Dhr1p, a putative DEAH-box RNA helicase, is associated with the box C+D snoRNP U3.

Authors:  A Colley; J D Beggs; D Tollervey; D L Lafontaine
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

9.  A complex pathway for 3' processing of the yeast U3 snoRNA.

Authors:  Joanna Kufel; Christine Allmang; Loredana Verdone; Jean Beggs; David Tollervey
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

10.  Identification and characterization of Prp45p and Prp46p, essential pre-mRNA splicing factors.

Authors:  Michael Albers; Ann Diment; Mariela Muraru; Caroline S Russell; Jean D Beggs
Journal:  RNA       Date:  2003-01       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.